Last $37.80 USD
Change Today +0.29 / 0.77%
Volume 56.9K
MYGN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 10:11 AM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

T. Craig Benson

President of Myriad Rbm, Myriad Genetics Inc.
AgeTotal Calculated CompensationThis person is connected to 16 board members in 2 different organizations across 4 different industries.

See Board Relationships
52--

Background*

Mr. T. Craig Benson served as the President of Myriad Rbm at Myriad Genetics Inc. Mr. Benson has been President and Secretary of Rules-Based Medicine, Inc. since 2002 and its Chief Executive Officer since 2004. Mr. Benson joined Luminex Corporation in January 2002 to direct the spin-off of Rules-Based Medicine. From 1987 to September 2000, Mr. Benson was employed by Service Corporation International. During his tenure with SCI, he held various senior executive management ...

Read Full Background

Corporate Headquarters*

320 Wakara Way
Salt Lake City, Utah 84108

United States

Phone: 801-584-3600
Fax: 801-584-3640

Board Members Memberships*

Director
2002-N/A
Former Chief Executive Officer, President, Secretary and Director
2008-Present
Director, Chief Executive Officer of Rules-Based Medicine Inc, President of Rules-Based Medicine Inc, Secretary of Rules-Based Medicine Inc and Director of Rules-Based Medicine Inc

Education*

Bachelor's Degree 1984
Southern Methodist University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MYGN:US $37.80 USD +0.29

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Joseph A. Chlapaty Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Advanced Drainage Systems, Inc.
$454.2K
Marc D. Grodman M.D.Founder, Chairman, Chief Executive Officer, President and Managing Director
Bio-Reference Laboratories Inc.
$1.2M
Russell Cummings Chief Executive Officer, Executive Director, and Member of Investment Committee
Imperial Innovations Group plc
210.0K GBP
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$600.0K
Michael J. Pellini M.D., MBAChief Executive Officer, President and Director
Foundation Medicine, Inc.
$403.9K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MYRIAD GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.